Genomic testing before active surveillance for low risk #prostatecancer #EAU18 by Dr Cooperberg – genomics will be integrated soon to tailor tx decisions https://t.co/51bmzfqhLE
Genomic testing before active surveillance for low risk #prostatecancer #EAU18 by Dr Cooperberg – genomics will be integrated soon to tailor tx decisions https://t.co/51bmzfqhLE